What We're Reading: Page 301
Industry reads hand-picked by our editors
May 04, 2017
-
Bloomberg
Inside the secret room where drug prices are set
-
Reuters
Bayer, J&J win first trial over Xarelto bleeding risks
-
The JAMA Network
Obstacles to the adoption of biosimilars for chronic diseases
-
MIT Technology Review
An AI-driven genomics company is turning to drugs
May 03, 2017
May 02, 2017
-
The Wall Street Journal
Mylan Chairman Received Nearly $100 Million Last Year
-
BloombergGadfly
The NIH looks Trump-proof
-
Triangle Business Journal
Cempra loses executive, but eyes FDA feedback
-
Quartz
Virtual-reality worlds filled with penguins and otters are a promising alternative to painkillers
May 01, 2017
Apr 28, 2017
-
The Washington Post
More than a million patients flock to this website. Drug companies are in hot pursuit.
-
Reuters
South Korea fines Novartis $49 million over kickbacks, suspends insurance payment
-
Vox
Google is super secretive about its anti-aging research. No one knows why.
-
MobiHealthNews
With $10M from Sanofi-Genzyme BioVentures, Evidation Health sets sights on pharma
Apr 27, 2017
-
Kaiser Health News
Negotiating drug prices: Should state agencies band together?
-
Regulatory Focus
Supreme Court weighs biosimilar patent dance
-
Smithsonian
Keeping vaccines safe in tiny "cages"
-
NPR
Welcome to the poison garden: Medicine's medieval roots
Apr 26, 2017
-
The New York Times
The C.E.O. of H.I.V.
-
Axios
Here's who is spending the most on health care lobbying
-
Financial Times
WHO steps closer to eliminating tropical disease
-
Forbes
Four decades of hacking biotech and yet biology still consumes everything
Previous
